Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2024-04-02 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Acquisition
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges (BSE and NSE) regarding an investment made by the company in another entity, ZIMTAS Pty Ltd. It references Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events or information. The document is brief (2221 characters) and serves as an announcement of a corporate event (investment) rather than a detailed financial report or analysis. There are no financial statements, management discussion, or detailed financial data present. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like Capital/Financing Update or Annual Report.
2024-04-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window for insiders due to upcoming financial results. It references SEBI regulations on insider trading and specifies the trading window closure dates around the financial results announcement for the quarter and year ended 31 March 2024. The document does not contain any financial data, results, or detailed report content but is an announcement related to compliance and trading restrictions. It is short (2238 characters) and serves as a regulatory compliance notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance and regulatory announcements that do not fit other specific categories.
2024-03-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of a duplicate share certificate due to loss or misplacement by a shareholder. It references Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about compliance and shareholder documentation, specifically the issuance of a duplicate share certificate. It does not contain financial data, earnings, management discussion, or any report-type content. It is an official notification related to share certificates, which fits best under Regulatory Filings (RNS) as it is a compliance announcement that does not fit other specific categories like share issue or director dealings.
2024-03-27 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the issuance of a duplicate share certificate due to loss or misplacement by a shareholder. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is an intimation about a share certificate issuance, not a financial report, management change, or other types of filings. It is a regulatory announcement related to share certificates but does not fit into categories like Share Issue/Capital Change or Transaction in Own Shares since it concerns duplicate certificates. Given the nature and length of the document (2166 characters), it is a regulatory filing notifying the stock exchanges of a compliance matter. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-03-20 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates due to loss or misplacement by shareholders. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate issuance and compliance. The content is about notifying the exchanges of the issuance of duplicate share certificates, which is a compliance and regulatory disclosure related to share capital but does not involve financial results, management changes, or other report types. The document length is short (2384 characters) and is a notification rather than a report or detailed filing. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance announcements that do not fit other specific categories.
2024-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges (BSE and NSE) regarding the schedule of an Investors / Analysts Meet. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The document does not contain any financial statements, detailed financial data, or report content. It is an announcement about an upcoming investor meeting, not a report or transcript of the meeting itself. The document length is under 5,000 characters and serves as a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.